PL2593129T3 - Nonapeptyd pat do stosowania w leczeniu choroby alzheimera - Google Patents

Nonapeptyd pat do stosowania w leczeniu choroby alzheimera

Info

Publication number
PL2593129T3
PL2593129T3 PL11752254T PL11752254T PL2593129T3 PL 2593129 T3 PL2593129 T3 PL 2593129T3 PL 11752254 T PL11752254 T PL 11752254T PL 11752254 T PL11752254 T PL 11752254T PL 2593129 T3 PL2593129 T3 PL 2593129T3
Authority
PL
Poland
Prior art keywords
disease
treating alzheimer
pat nonapeptide
nonapeptide
pat
Prior art date
Application number
PL11752254T
Other languages
English (en)
Inventor
Jamal Temsamani
Claude Laruelle
Original Assignee
Cll Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cll Pharma filed Critical Cll Pharma
Publication of PL2593129T3 publication Critical patent/PL2593129T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/32—Thymopoietins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PL11752254T 2010-07-12 2011-07-11 Nonapeptyd pat do stosowania w leczeniu choroby alzheimera PL2593129T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1002965A FR2962335B1 (fr) 2010-07-12 2010-07-12 Utilisation du nonapeptide pat dans le traitement et la prevention des maladies neurodegeneratives
EP11752254.0A EP2593129B1 (fr) 2010-07-12 2011-07-11 Nonapeptide pat pour son utilisation dans le traitement de la maladie d'alzheimer
PCT/FR2011/000410 WO2012007658A2 (fr) 2010-07-12 2011-07-11 Utilisation du nonapeptide pat dans le traitement et la prevention des maladies neurodegeneratives

Publications (1)

Publication Number Publication Date
PL2593129T3 true PL2593129T3 (pl) 2015-11-30

Family

ID=42985529

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11752254T PL2593129T3 (pl) 2010-07-12 2011-07-11 Nonapeptyd pat do stosowania w leczeniu choroby alzheimera

Country Status (5)

Country Link
US (1) US9192654B2 (pl)
EP (1) EP2593129B1 (pl)
FR (1) FR2962335B1 (pl)
PL (1) PL2593129T3 (pl)
WO (1) WO2012007658A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU24626B1 (es) 2019-12-26 2022-11-07 Centro Nac De Biopreparados Composición farmacéutica a base de proteínas con actividad neuroprotectora, inmunomoduladora, antiinflamatoria y antimicrobiana

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5852225A (ja) * 1981-09-22 1983-03-28 Mitsui Pharmaceut Inc 脱髄疾患治療剤
US4663318A (en) 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
DE3805744C2 (de) 1987-03-04 1999-09-23 Novartis Ag Phenylcarbamate zur Hemmung der Acetylcholinesterase
FI95572C (fi) 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
DE58905637D1 (de) 1989-04-14 1993-10-21 Merz & Co Gmbh & Co Verwendung von Adamantan-Derivaten zur Prävention und Behandlung der cerebralen Ischämie.
CA2026306A1 (en) 1989-10-04 1991-04-05 Akira Awaya Medicament for prevention and remedy of disorders of decrease in the number of blood corpuscles
JPH07504203A (ja) 1992-09-15 1995-05-11 イミュネックス・コーポレーション 腫瘍壊死因子アンタゴニストを用いるｔｎｆ−依存性炎症の治療方法
ATE300952T1 (de) * 1999-12-09 2005-08-15 Chiron Corp Verfahren zur verabreichung von wirkstoffen in das zentrale nervensystem oder lymphsystem
FR2830451B1 (fr) * 2001-10-09 2004-04-30 Inst Nat Sante Rech Med Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur
AU2008261888A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
FR2930156B1 (fr) 2008-04-21 2011-10-28 Cll Pharma Utilisation du nonapeptide pat dans le traitement des maladies autoimmunes.

Also Published As

Publication number Publication date
FR2962335B1 (fr) 2013-01-18
WO2012007658A2 (fr) 2012-01-19
WO2012007658A3 (fr) 2012-03-22
US9192654B2 (en) 2015-11-24
WO2012007658A4 (fr) 2012-05-10
EP2593129B1 (fr) 2015-03-18
EP2593129A2 (fr) 2013-05-22
FR2962335A1 (fr) 2012-01-13
US20130116193A1 (en) 2013-05-09

Similar Documents

Publication Publication Date Title
EP2707369A4 (en) COMPOSITIONS AND METHODS FOR TREATING ALZHEIMER'S DISEASE
PL2985032T3 (pl) Glyx do stosowania do leczenia choroby alzheimera, choroby parkinsona lub choroby huntingtona
IL213259A0 (en) Composition for the use to treat alzheimer's disease
ZA201007460B (en) Use of epothelone in treating tau-associated disease including alzheimer's disease
PT3042910T (pt) 2'-espiro-nucleósidos para utilização na terapia da hepatite c
IL218985A0 (en) Siglec 15 antibodies in treating bone loss-related disease
IL219412A (en) Preparations containing Busimanden for use in the treatment of Alzheimer's or Alzheimer's disease
SI2892563T1 (sl) Farmacevtski sestavki za zdravljenje alzheimerjeve bolezni
SG11201403272YA (en) Compositions and methods for treating alzheimer's disease
ZA201406916B (en) New therapeutic approaches for treating parkinson's disease
EP2485733A4 (en) METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
PT2424870E (pt) Agentes terapêuticos 713
ZA201402477B (en) Compounds for use in the treatment of alzheimer's disease
SG11201406093VA (en) An h3 receptor antagonist for use in the treatment of alzheimer's disease
PL2565184T3 (pl) Środek terapeutyczny i środek zapobiegawczy przeciwko chorobie alzheimera
PL2556834T3 (pl) Tetratiomolibdenian do stosowania w leczeniu uszkodzenia niedokrwiennoreperfuzyjnego serca
IL216717A0 (en) USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES
PL2593129T3 (pl) Nonapeptyd pat do stosowania w leczeniu choroby alzheimera
PL2265279T3 (pl) Zastosowanie nonapeptydu pat w leczeniu chorób autoimmunologicznych
IL214340A0 (en) Methods and compositions for treating alzheimer's disease
GB201104720D0 (en) Carncin - The use of L-carnosine and cinnamon in the treatment of alzheimer's disease
GB201018325D0 (en) Treatment for dupuytren's disease
HK1195902A (en) Compositions and methods for treating alzheimer's disease
GB201020792D0 (en) Peptide agents for use in therapy
AU334057S (en) Women's clothing - top